Christopher N. Boddy
9Patents
1h-index
12Co-inventors
44Inventor score
Filing activity: Sep 26, 2007 → Mar 31, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10654839B2 | Compositions and methods for viral sensitization | Emerging Cross-Sectional Technologies | 2 | Active |
| US9512455B2 | Cell-based production of nonulosonates | Chemistry; Metallurgy | 1 | Active |
| US9243240B2 | Metabolically engineered escherichia coli for enhanced production of sialic acid | Chemistry; Metallurgy | 0 | Active |
| US11339146B2 | Compositions and methods for viral sensitization | Emerging Cross-Sectional Technologies | 0 | Active |
| US8841099B2 | Cell-based production of nonulosonates | Chemistry; Metallurgy | 0 | Active |
| US10301659B2 | Cell-based production of nonulosonates | Chemistry; Metallurgy | 0 | Active |
| US8709781B2 | System and method for the heterologous expression of polyketide synthase gene clusters | Chemistry; Metallurgy | 0 | Active |
| US8722365B2 | Metabolically engineered Escherichia coli for enhanced production of sialic acid | Chemistry; Metallurgy | 0 | Active |
| US12195451B2 | Compositions and methods for viral sensitization | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.